Constipation during Entecavir treatment in Chronic Hepatitis B patients: Two Cases Reports
<p>Entecavir (ETV) is an oral nucleoside analog inhibitor of hepatitis B virus (HBV) DNA polymerase, which is widely used in patients with chronic hepatitis B (CHB). Despite the excellent safety data of this agent, the adverse events of headache, diarrhea, nausea and vomiting are recorded in t...
Saved in:
Main Authors: | Meng-Lan Wang (Author), Dong-Mei Zhang (Author), En-Qiang Chen (Author) |
---|---|
Format: | Book |
Published: |
Archives of Hepatitis Research - Peertechz Publications,
2017-05-29.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Entecavir Treatment in Children and Adolescents with Chronic Hepatitis B Virus Infection
by: Kai-Chi Chang, et al.
Published: (2016) -
Clinical utility of entecavir for chronic hepatitis B in Chinese patients
by: Wang JY
Published: (2013) -
Comparison of the effectiveness and renal safety of tenofovir versus entecavir in patients with chronic hepatitis B
by: Beatriz López Centeno, et al.
Published: (2016) -
Cost-effectiveness analysis of lamivudine, telbivudine, and entecavir in treatment of chronic hepatitis B with adefovir dipivoxil resistance
by: Wang G, et al.
Published: (2015) -
Virologic breakthrough in a patient with chronic hepatitis B by combination treatment with tenofovir disoproxil fumarate and entecavir
by: Suzuki F, et al.
Published: (2014)